These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21560651)

  • 21. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
    Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
    Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury.
    Agrawal NM; Dajani EZ
    Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat.
    Menozzi A; Pozzoli C; Giovannini E; Solenghi E; Grandi D; Bonardi S; Bertini S; Vasina V; Coruzzi G
    Eur J Pharmacol; 2006 Dec; 552(1-3):143-50. PubMed ID: 17069793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous prostaglandin E2 accelerates healing of indomethacin-induced small intestinal lesions through upregulation of vascular endothelial growth factor expression by activation of EP4 receptors.
    Takeuchi K; Tanigami M; Amagase K; Ochi A; Okuda S; Hatazawa R
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S67-74. PubMed ID: 20586869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of intestinal, but not gastric damage caused by a low dose of indomethacin in the presence of rofecoxib.
    Yokota A; Taniguchi M; Tanaka A; Takeuchi K
    Inflammopharmacology; 2005; 13(1-3):209-16. PubMed ID: 16259740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental study of the impact of a single use of indometacine on the morphological structure of the mucous coat of the stomach and small intestine].
    Vymiatina ZK; Ivanova LA; Krylova SG
    Eksp Klin Gastroenterol; 2006; (3):32-6, 70. PubMed ID: 17203840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Modern approach to the prevention and treatment of NSAID-gastropathy].
    Drozdov VN; Kim VA; Lazebnik LB
    Eksp Klin Gastroenterol; 2011; (2):106-10. PubMed ID: 21560649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of prostaglandins against nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury.
    Dajani EZ; Agrawal NM
    Int J Clin Pharmacol Res; 1989; 9(6):359-69. PubMed ID: 2699464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prophylaxis and therapy of gastropathy caused by non-steroidal anti-inflammatory drugs].
    László A
    Orv Hetil; 2002 Jul; 143(27):1643-8. PubMed ID: 12180001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Endoscopic changes in the stomach and duodenal mucosa caused by microdose acetylsalicylic acid therapy and their prevention--editorial].
    Ehrmann J; Procházka V; Konecný M; Spacek M; Urbánek K
    Vnitr Lek; 2007 Oct; 53(10):1024-8. PubMed ID: 18072422
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanisms of gastrointestinal damage by NSAIDS.
    Rainsford KD
    Agents Actions Suppl; 1993; 44():59-64. PubMed ID: 8372736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New NSAIDs and gastroduodenal damage.
    Folco GC
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():28-9. PubMed ID: 9032579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenic mechanism of NSAIDs-induced mucosal injury in lower gastrointestinal tract].
    Beppu K; Osada T; Shibuya T; Watanabe S
    Nihon Rinsho; 2011 Jun; 69(6):1083-7. PubMed ID: 21688632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
    Amagase K; Ochi A; Sugihara T; Kato S; Takeuchi K
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S111-8. PubMed ID: 20586851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non steroidal anti-inflammatory drugs. Minimising the harm, maximising the benefit.
    Hawkey CJ
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):48-9. PubMed ID: 9615265
    [No Abstract]   [Full Text] [Related]  

  • 37. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemopexin is upregulated in rat intestinal mucosa injured by indomethacin.
    Takagi T; Naito Y; Okada H; Takaoka M; Oya-Ito T; Yamada S; Hirai Y; Mizushima K; Yoshida N; Kamada K; Katada K; Uchiyama K; Ishikawa T; Handa O; Yagi N; Konishi H; Kokura S; Ichikawa H; Yoshikawa T
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():70-5. PubMed ID: 22486875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral glutamine attenuates indomethacin-induced small intestinal damage.
    Basivireddy J; Jacob M; Balasubramanian KA
    Clin Sci (Lond); 2004 Sep; 107(3):281-9. PubMed ID: 15128285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention and treatment of upper gastrointestinal bleeding by nonsteroidal anti-inflammatory drugs].
    Bar-Dayan Y; Levi Y
    Harefuah; 1996 Apr; 130(8):535-7. PubMed ID: 8765878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.